(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.23%) $83.66
(-1.16%) $1.619
(0.10%) $2 349.60
(-0.07%) $27.52
(0.25%) $924.40
(0.37%) $0.935
(0.57%) $11.01
(0.17%) $0.801
(0.00%) $92.17
4 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 4.65%
-1.94% INR 1 219.60
Live Chart Being Loaded With Signals
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India...
Stats | |
---|---|
Šios dienos apimtis | 41 169.00 |
Vidutinė apimtis | 71 165.00 |
Rinkos kapitalizacija | 23.92B |
EPS | INR0 ( 2024-04-04 ) |
Kita pelno data | ( INR0 ) 2024-05-02 |
Last Dividend | INR1.500 ( 2023-07-20 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -46.93 |
ATR14 | INR1.958 (0.16%) |
Tūris Koreliacija
Astec LifeSciences Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
ATUL.NS | 0.945 |
PFIZER.NS | 0.943 |
FINEORG.NS | 0.942 |
LALPATHLAB.NS | 0.942 |
BATAINDIA.NS | 0.939 |
ENIL.NS | 0.938 |
LAURUSLABS.NS | 0.938 |
HDFCAMC.NS | 0.937 |
INSECTICID.NS | 0.935 |
BIOCON.NS | 0.933 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
JSL.NS | -0.935 |
ISMTLTD.NS | -0.924 |
JSLHISAR.NS | -0.915 |
JINDALSAW.NS | -0.909 |
DFMFOODS.NS | -0.906 |
4THDIM.NS | -0.9 |
NEWGEN.NS | -0.899 |
KIRLFER.NS | -0.898 |
OIL.NS | -0.897 |
LTGILTBEES.NS | -0.897 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Astec LifeSciences Koreliacija - Valiuta/Žaliavos
Astec LifeSciences Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR6.28B |
Bruto pelnas: | INR2.27B (36.12 %) |
EPS: | INR13.04 |
FY | 2022 |
Pajamos: | INR6.28B |
Bruto pelnas: | INR2.27B (36.12 %) |
EPS: | INR13.04 |
FY | 2022 |
Pajamos: | INR6.77B |
Bruto pelnas: | INR2.86B (42.23 %) |
EPS: | INR45.87 |
FY | 2021 |
Pajamos: | INR5.55B |
Bruto pelnas: | INR2.10B (37.79 %) |
EPS: | INR33.23 |
Financial Reports:
No articles found.
Astec LifeSciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR1.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR1.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.000 | 2010-08-12 |
Last Dividend | INR1.500 | 2023-07-20 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | INR15.50 | -- |
Avg. Dividend % Per Year | 0.08% | -- |
Score | 0.85 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 2.32 | |
Div. Directional Score | 0.626 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.500 | 0.21% |
2019 | INR1.500 | 0.28% |
2020 | INR1.500 | 0.34% |
2021 | INR1.500 | 0.12% |
2022 | INR1.500 | 0.10% |
2023 | INR1.500 | 0.09% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TINPLATE.NS | Dividend Junior | 2023-08-11 | Annually | 19 | 0.72% | |
PDMJEPAPER.NS | Dividend Junior | 2023-08-03 | Annually | 9 | 0.65% | |
J&KBANK.NS | Dividend Junior | 2023-08-17 | Sporadic | 22 | 0.47% | |
DATAMATICS.NS | Dividend Junior | 2023-09-22 | Annually | 21 | 0.49% | |
SHYAMMETL.NS | Dividend Junior | 2023-06-05 | Semi-Annually | 4 | 0.70% | |
MAXHEALTH.NS | Dividend Junior | 2023-09-08 | Insufficient data to determine frequency | 2 | 0.07% | |
GSPL.NS | Dividend Junior | 2023-09-01 | Annually | 19 | 0.81% | |
BANKINDIA.NS | Dividend Junior | 2023-06-20 | Sporadic | 23 | 1.34% | |
PRAJIND.NS | Dividend Junior | 2023-07-19 | Annually | 22 | 0.83% | |
KABRAEXTRU.NS | Dividend Junior | 2023-07-13 | Annually | 23 | 0.83% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.118 | 1.500 | -2.36 | -3.54 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.125 | 1.500 | -2.50 | -3.75 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -1.754 | 1.000 | -1.761 | -1.761 | [3 - 30] |
operatingCashFlowPerShareTTM | 27.96 | 2.00 | 0.680 | 1.361 | [0 - 30] |
freeCashFlowPerShareTTM | 27.96 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.304 | 1.000 | 8.26 | 8.26 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.101 | 1.000 | -4.03 | -4.03 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -1.067 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -46.95 | 1.000 | -4.84 | 0 | [1 - 100] |
returnOnEquityTTM | -0.125 | 2.50 | -1.608 | -3.75 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 27.96 | 2.00 | 0.680 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.123 | 1.500 | 6.93 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 27.96 | 2.00 | 0.680 | 1.361 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.656 | 1.500 | 8.96 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.127 | 1.000 | 9.32 | 0 | [0.1 - 0.5] |
Total Score | 2.32 |
Astec LifeSciences
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.